Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 26 most recent Form 4 transactions.
| PCVX |
| Vaxcyte, Inc. |
| FTAX |
| 1,273 |
| $60.74 |
| $77.3K |
| -1.2% |
| Open the original filing on SEC.gov |
| Aug 3 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 3 | PCVX | Vaxcyte, Inc. | SSELL◷ | 3,044 | $54.18 | $164.9K | -2.8% | Open the original filing on SEC.gov |
| Aug 3 | PCVX | Vaxcyte, Inc. | SSELL◷ | 6,956 | $53.76 | $374K | -6.0% | Open the original filing on SEC.gov |
| Aug 3 | PCVX | Vaxcyte, Inc. | MEXER◷ | 10,000 | $5.35 | $53.5K | +9.5% | Open the original filing on SEC.gov |
| Jul 6 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 6 | PCVX | Vaxcyte, Inc. | SSELL◷ | 2,087 | $57.76 | $120.6K | -2.0% | Open the original filing on SEC.gov |
| Jul 6 | PCVX | Vaxcyte, Inc. | SSELL◷ | 7,913 | $57.16 | $452.3K | -6.9% | Open the original filing on SEC.gov |
| Jul 6 | PCVX | Vaxcyte, Inc. | MEXER◷ | 10,000 | $5.35 | $53.5K | +9.6% | Open the original filing on SEC.gov |
| Jun 18 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | PCVX | Vaxcyte, Inc. | SSELL◷ | 10,000 | $53.00 | $530K | -8.7% | Open the original filing on SEC.gov |
| Jun 18 | PCVX | Vaxcyte, Inc. | MEXER◷ | 10,000 | $5.35 | $53.5K | +9.6% | Open the original filing on SEC.gov |
| Mar 9 | PCVX | Vaxcyte, Inc. | FTAX | 1,021 | $59.32 | $60.6K | -1.0% | Open the original filing on SEC.gov |
| Mar 2 | PCVX | Vaxcyte, Inc. | FTAX | 1,009 | $61.98 | $62.5K | -0.9% | Open the original filing on SEC.gov |
| Feb 28 | PCVX | Vaxcyte, Inc. | FTAX | 898 | $61.98 | $55.7K | -0.8% | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT◆ | 74,993 | — | — | — | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT | 44,864 | — | — | +71.8% | Open the original filing on SEC.gov |
| Feb 20 | CRBU | Caribou Biosciences, Inc. | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 14 | PCVX | Vaxcyte, Inc. | GGIFT | 61,850 | — | — | — | Open the original filing on SEC.gov |
| Jan 14 | PCVX | Vaxcyte, Inc. | GGIFT | 61,850 | — | — | -49.8% | Open the original filing on SEC.gov |
| Sep 8, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 2,890 | $32.41 | $93.7K | -2.3% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 1,429 | $31.56 | $45.1K | -1.1% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 2,381 | $31.56 | $75.1K | -1.8% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 1,270 | $31.56 | $40.1K | -1.0% | Open the original filing on SEC.gov |